Showing results (381-390 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|September 20, 2015
Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare settingKostas Athanasakis, Eleftheria Karampli, Dimitrios Tsounis, et al.Clinical Drug Investigation|October 9, 2015
Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysisTakamasa Ohki, Koki Sato, Mari Yamagami, et al.Clinical Drug Investigation|October 29, 2015
Antiplatelet Efficacy of Fixed-Dose Aspirin-Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent ImplantationSungmin Lim, Pum Joon Kim, Chunyeong Baek, et al.Clinical Drug Investigation|October 18, 2015
Teneligliptin: a review in type 2 diabetesLesley J ScottClinical Drug Investigation|October 21, 2015
Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot StudyShigemasa Tani, Ken Nagao, Atsushi HirayamaClinical Drug Investigation|February 3, 2016
The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL StudyAyman Abdelhady, Said Khader, Samy Sinnuqrut, et al.Clinical Drug Investigation|February 26, 2016
Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 InhibitorsTakamasa Ohki, Akihiro Isogawa, Nobuo Toda, et al.Clinical Drug Investigation|September 4, 2015
Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral AdministrationHartley C Atkinson, Ioana Stanescu, Chris Frampton, et al.Clinical Drug Investigation|August 13, 2015
Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteersCathy K Gelotte, Brenda A ZimmermanClinical Drug Investigation|August 26, 2015
Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomyLourdes Ferreira Laso, Amanda López Picado, Fernando Antoñanzas Villar, et al.Pageof 233